M1A.472
Other secondary chronic gout, left ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary chronic gout is a persistent form of gout that affects the joints, often resulting from underlying health conditions or medication use. The condition leads to episodes of joint pain, swelling, and inflammation, typically involving the ankle and foot. When this form of gout becomes chronic, it can cause ongoing joint damage and discomfort, significantly impacting daily activities. Recognizing the features of secondary chronic gout, especially in the left ankle and foot, is important for effective management and maintaining joint function.
Causes & Symptoms
Clinical Causes: Prolonged elevated uric acid levels in the blood, leading to crystal formation in joints Chronic kidney disease impairing uric acid excretion Certain medications, such as diuretics or immunosuppressants, increasing uric acid levels Metabolic conditions like obesity and hypertension that predispose to gout Genetic predisposition affecting uric acid metabolism Repeated episodes of acute gout leading to a chronic condition if untreated Underlying joint disorders or injuries that aggravate gout symptoms
Key Symptoms: Persistent joint swelling and pain in the affected ankle and foot Presence of tophi, which are deposits of uric acid crystals under the skin Stiffness and limited range of motion in the affected joints Redness and warmth over the joints during flare-ups Discomfort that worsens with stress, certain foods, or alcohol consumption Possible joint deformity or joint destruction over time with chronicity Recurring episodes that can become more frequent and severe without proper treatment
Diagnostic & Treatment
Diagnosis Path: Diagnosis of secondary chronic gout typically involves a combination of clinical evaluation, medical history review, and laboratory tests. Key diagnostic steps include: - Physical examination focusing on the affected joints - Blood tests to measure serum uric acid levels - Joint fluid analysis to identify uric acid crystals under microscopy - Imaging studies such as X-rays or ultrasound to assess joint damage and crystal deposits - Evaluation for underlying conditions like kidney dysfunction or metabolic disorders that may contribute to gout The goal is to differentiate gout from other causes of chronic joint inflammation and to identify factors that can be managed to improve patient outcomes.
Treatment Protocols: Managing secondary chronic gout aims to reduce joint inflammation, prevent damage, and control uric acid levels. Common approaches include: - Medications to lower uric acid levels, such as allopurinol or febuxostat - Anti-inflammatory drugs like NSAIDs, colchicine, or corticosteroids during flare-ups - Lifestyle modifications including weight management, dietary changes, and limiting alcohol intake - Addressing underlying health conditions like kidney disease or hypertension - Regular monitoring of uric acid levels and joint health - Physical therapy or joint support to maintain mobility and function Long-term management often involves a combination of medication adherence and lifestyle changes to control the disease and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M1A.472 a billable ICD-10 code?
Yes, M1A.472 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.472?
Clinical documentation must specify the nature of Other secondary chronic gout, left ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference